Conferences

Our Conferences articles contain the latest coverage of medical advancements from recent academic conferences.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

Testing a New Combination Therapy for Myelofibrosis Treatment

August 12, 2024

Navitoclax with Ruxolitinib in Phase III trial shows promise for myelofibrosis, significantly reducing spleen size and improving patient symptoms.

ASCO 2024: The MANIFEST-2 Study for Myelofibrosis

June 12, 2024

Discover the latest in myelofibrosis: Phase 3 study shows promising results for Pelabresib + Ruxolitinib, reducing spleen size and improving symptoms.

What is the ASCO Conference?

May 27, 2024

The American Society of Clinical Oncology holds a yearly conference in June to allow researchers and doctors in the cancer community an opportunity to share…

ASH 2023: Navitoclax And Ruxolitinib Trials to Treat Myelofibrosis

February 26, 2024

ASH 2023 results reveal that a JAK inhibitor combined with navitoclax, a BCL-2 inhibitor showed success in myelofibrosis.

ASH 2023: Cardiovascular Complications and Myelofibrosis

January 08, 2024

A study at the 2023 ASH conference compared heart disease complications among myelofibrosis patients who received ruxolitinib vs those who did not.

ASH 2023: Phase 1/2 Study Of Zilurgisertib Monotherapy And In Combination With Ruxolitinib For Anemic Myelofibrosis Patients

January 05, 2024

myelofibrosis and anemia, zilurgisertib and myelofibrosis, clincial trial for myelofibrosis, life with myelofibrosis

What is the ASH Conference?

December 01, 2023

The American Society of Hematology holds a yearly conference in December to allow researchers and doctors in the blood cancer community an opportunity to...